Ethyl 2-(2-((3-(4-bromophenyl)-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetamido)acetate

Catalog No. :
ACKXPA096
CAS No. :
618880-58-3
Molecular Formula :
C22H22BrN3O4S2
Molecular Weight :
536.47

IUPAC Name:ethyl (2-((3-(4-bromophenyl)-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetyl)glycinate

Ethyl 2-(2-((3-(4-bromophenyl)-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetamido)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(2-((3-(4-bromophenyl)-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetamido)acetate
IUPAC Nameethyl (2-((3-(4-bromophenyl)-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetyl)glycinate
MDL No.MFCD03473563
Molecular FormulaC22H22BrN3O4S2
Molecular Weight536.47
SMILESO=C(OCC)CNC(CSC1=NC2=C(C3=C(CCCC3)S2)C(N1C4=CC=C(Br)C=C4)=O)=O
InChI KeyVRVGROBVOIJBKQ-UHFFFAOYSA-N
SynonymETHYL [(([3-(4-BROMOPHENYL)-4-OXO-3,4,5,6,7,8-HEXAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-2-YL]SULFANYL)ACETYL)AMINO]ACETATE;SALOR-INT L415774-1EA
CAS No.618880-58-3

Synthetic Route by SureRoute

1. ACKXPA096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDIT374 route compound structure diagram
    ACBDIT374623-33-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKXPA096 route product structure diagram
    ACKXPA096618880-58-3
Inquiry

2. ACKXPA096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDIT374 route compound structure diagram
    ACBDIT374623-33-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKXPA096 route product structure diagram
    ACKXPA096618880-58-3
Inquiry

Comments (0)